Navigation Links
Joint Venture Formed to Help Health Marketers Navigate Social Media Environment
Date:10/28/2009

NEW YORK, Oct. 28 /PRNewswire/ -- Extrovertic and Virilion announced today a joint venture, EV Healthcare, to help healthcare companies engage consumers in an increasingly social communications environment.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091028/PH00703LOGO )

"Innovating to meet the perpetually evolving needs of digital, social and mobile consumers is hard enough," says Dorothy Wetzel, co-founder and executive marketer at Extrovertic. "Doing it in the politically and emotionally charged healthcare arena is the ultimate challenge. But with Virilion's more than a decade of experience dealing with cause-related issues and crisis management, this venture greatly enhances our ability to create new 'pharma-safe' solutions that build brands."

"Virilion has long specialized in digital and social media for categories in the public eye," said Dan Solomon, CEO of Virilion. "We believe this competence, combined with Extrovertic's deep healthcare knowledge and creative acumen, will help pharma clients more effectively engage consumers in today's changing communications environment."

"DTC advertising is under assault. Clients today need new non-traditional creative solutions to help them tell more cohesive and engaging stories across all channels," added Mark Drossman, Extrovertic's co-founder and executive creative director, "and in the process, create more engaged brand advocates."

Extrovertic was founded by industry veterans Dorothy Wetzel -- formerly of Saatchi Healthcare and Pfizer Consumer Marketing -- and Mark Drossman -- formerly of Ogilvy and Euro RSCG -- in January. The agency's client roster includes a number of biotech companies.

Virilion has offices in Austin, Boston, New York and Washington, DC. Since 1997, the firm has worked for clients in categories ranging from food, agriculture and energy to media and entertainment. In the healthcare sector, Virilion has worked for Abbott, the Pharmaceutical Manufacturers of America, and Easter Seals.

EV Healthcare will be led out of the firms' New York offices.

    CONTACT: Mimi Carter, Publicist
    VIRILION
    mcarter@virilion.com
    202.654.0800

SOURCE EV Healthcare


'/>"/>
SOURCE EV Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
2. Joint Commission Urges Patients to Speak Up About Pain
3. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
4. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
7. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
8. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
9. When to Have That Joint Replacement?
10. Beating Blood Clots after Joint Replacement
11. Octogenarians: Not Too Old for Joint Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... SAN DIEGO , Dec. 9, 2016 /PRNewswire/ ... with Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ... program targeting ,LpxC, for the treatment of bacterial ... LpxC has been recognized as an attractive antibacterial ... however, a lack of suitable chemical starting points ...
(Date:12/8/2016)... , Dec. 8, 2016  The global biosurgery market ... during the forecast period of 2016 to 2021. The ... 2021 from USD 18.21 billion in 2016. The market ... incidences of sports related injuries and spinal problems, increasing ... need of effective blood loss management. In ...
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... "TransPanel Volume 2 is ... unique animations," said Christina Austin - CEO of Pixel Film Studios. , TransPanel ... FCPX . This set of versatile transitions features presets with up to ...
(Date:12/10/2016)... PITTSBURGH, PA (PRWEB) , ... December 10, 2016 , ... ... Jacksonville, Fla., worried about germs spreading from the seat to her body, and contamination ... but convenient and effective way to solve this problem that many people face. , ...
(Date:12/9/2016)... ... 2016 , ... Cellairis is a worldwide mobile device and computer repair franchise ... iPad and Samsung Galaxy devices with premium parts and accessories. Cellairis has recently ... and accessibility for customers. While customers do their shopping, Cellairis can accomplish a number ...
(Date:12/9/2016)... ... 2016 , ... The Justin Veatch Fund announced Thursday that ... film Whispering Spirits and its discussion guide for use by all of ... in the war against teen drug abuse. NCADD is the oldest anti-addiction advocacy ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution ... transplantation while encouraging readers to sign up as an organ donor for the 123,000 ... , An organ donor can save up to 8 saves through organ donation ...
Breaking Medicine News(10 mins):